Literature DB >> 18375718

Characterization of the structural and functional changes in the myocardium following focal ischemia-reperfusion injury.

Navdeep Ojha1, Sashwati Roy, Jared Radtke, Orlando Simonetti, Surya Gnyawali, Jay L Zweier, Periannan Kuppusamy, Chandan K Sen.   

Abstract

High-resolution (11.7 T) cardiac magnetic resonance imaging (MRI) and histological approaches have been employed in tandem to characterize the secondary damage suffered by the murine myocardium following the initial insult caused by ischemia-reperfusion (I/R). I/R-induced changes in the myocardium were examined in five separate groups at the following time points after I/R: 1 h, day 1, day 3, day 7, and day 14. The infarct volume increased from 1 h to day 1 post-I/R. Over time, the loss of myocardial function was observed to be associated with increased infarct volume and worsened regional wall motion. In the infarct region, I/R caused a decrease in end-systolic thickness coupled with small changes in end-diastolic thickness, leading to massive wall thickening abnormalities. In addition, compromised wall thickening was also observed in left ventricular regions adjacent to the infarct region. A tight correlation (r2 = 0.85) between measured MRI and triphenyltetrazolium chloride (TTC) infarct volumes was noted. Our observation that until day 3 post-I/R the infarct size as measured by TTC staining and MRI was much larger than that of the myocyte-silent regions in trichrome- or hematoxylin-eosin-stained sections is consistent with the literature and leads to the conclusion that at such an early phase, the infarct site contains structurally intact myocytes that are functionally compromised. Over time, such affected myocytes were noted to structurally disappear, resulting in consistent infarct sizes obtained from MRI and TTC as well as trichrome and hematoxylin-eosin analyses on day 7 following I/R. Myocardial remodeling following I/R includes secondary myocyte death followed by the loss of cardiac function over time.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18375718      PMCID: PMC4772869          DOI: 10.1152/ajpheart.01190.2007

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  39 in total

1.  Characterization of perceived hyperoxia in isolated primary cardiac fibroblasts and in the reoxygenated heart.

Authors:  Sashwati Roy; Savita Khanna; William A Wallace; Jani Lappalainen; Cameron Rink; Arturo J Cardounel; Jay L Zweier; Chandan K Sen
Journal:  J Biol Chem       Date:  2003-09-02       Impact factor: 5.157

2.  Apoptosis is prevented by administration of superoxide dismutase in dogs with reperfused myocardial infarction.

Authors:  G Ambrosio; J L Zweier; L C Becker
Journal:  Basic Res Cardiol       Date:  1998-04       Impact factor: 17.165

3.  An improved MR imaging technique for the visualization of myocardial infarction.

Authors:  O P Simonetti; R J Kim; D S Fieno; H B Hillenbrand; E Wu; J M Bundy; J P Finn; R M Judd
Journal:  Radiology       Date:  2001-01       Impact factor: 11.105

4.  An increase in the myocardial PCr/ATP ratio in GLUT4 null mice.

Authors:  Robert G Weiss; John C Chatham; Dimitrios Georgakopolous; Maureen J Charron; Theo Wallimann; Laurence Kay; Bernd Walzel; Yibin Wang; David A Kass; Gary Gerstenblith; V P Chacko
Journal:  FASEB J       Date:  2002-04       Impact factor: 5.191

5.  Acute myocardial infarction in humans is associated with activation of programmed myocyte cell death in the surviving portion of the heart.

Authors:  G Olivetti; F Quaini; R Sala; C Lagrasta; D Corradi; E Bonacina; S R Gambert; E Cigola; P Anversa
Journal:  J Mol Cell Cardiol       Date:  1996-09       Impact factor: 5.000

6.  Characterization of viable and nonviable myocardium at MR imaging: comparison of gadolinium-based extracellular and blood pool contrast materials versus manganese-based contrast materials in a rat myocardial infarction model.

Authors:  Sebastian Flacke; John S Allen; Jon M Chia; James H Wible; M Peri Periasamy; Max D Adams; I Kofi Adzamli; Christine H Lorenz
Journal:  Radiology       Date:  2003-01-24       Impact factor: 11.105

7.  Early contrast-enhanced MRI predicts late functional recovery after reperfused myocardial infarction.

Authors:  W J Rogers; C M Kramer; G Geskin; Y L Hu; T M Theobald; D A Vido; S Petruolo; N Reichek
Journal:  Circulation       Date:  1999-02-16       Impact factor: 29.690

Review 8.  MR in mouse models of cardiac disease.

Authors:  Frederick H Epstein
Journal:  NMR Biomed       Date:  2007-05       Impact factor: 4.044

9.  Angiotensin II type 2 receptor overexpression preserves left ventricular function after myocardial infarction.

Authors:  Zequan Yang; Christina M Bove; Brent A French; Frederick H Epstein; Stuart S Berr; Joseph M DiMaria; Jennifer J Gibson; Robert M Carey; Christopher M Kramer
Journal:  Circulation       Date:  2002-07-02       Impact factor: 29.690

10.  Infarct resorption, compensatory hypertrophy, and differing patterns of ventricular remodeling following myocardial infarctions of varying size.

Authors:  David S Fieno; Hanns B Hillenbrand; Wolfgang G Rehwald; Kathleen R Harris; Robert S Decker; Michele A Parker; Francis J Klocke; Raymond J Kim; Robert M Judd
Journal:  J Am Coll Cardiol       Date:  2004-06-02       Impact factor: 24.094

View more
  24 in total

1.  Remodeling of the ischemia-reperfused murine heart: 11.7-T cardiac magnetic resonance imaging of contrast-enhanced infarct patches and transmurality.

Authors:  Surya C Gnyawali; Sashwati Roy; Molly McCoy; Sabyasachi Biswas; Chandan K Sen
Journal:  Antioxid Redox Signal       Date:  2009-08       Impact factor: 8.401

2.  Fra-2 mediates oxygen-sensitive induction of transforming growth factor beta in cardiac fibroblasts.

Authors:  Sashwati Roy; Savita Khanna; Ali Azad; Rebecca Schnitt; Guanglong He; Cora Weigert; Hidenori Ichijo; Chandan K Sen
Journal:  Cardiovasc Res       Date:  2010-04-28       Impact factor: 10.787

3.  Modulation of p38 kinase by DUSP4 is important in regulating cardiovascular function under oxidative stress.

Authors:  Alma Barajas-Espinosa; Ariel Basye; Mark G Angelos; Chun-An Chen
Journal:  Free Radic Biol Med       Date:  2015-07-14       Impact factor: 7.376

4.  Experimental model of transthoracic, vascular-targeted, photodynamically induced myocardial infarction.

Authors:  Adrian Chrastina; Peter Pokreisz; Jan E Schnitzer
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-11-08       Impact factor: 4.733

5.  MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue.

Authors:  Sashwati Roy; Savita Khanna; Syed-Rehan A Hussain; Sabyasachi Biswas; Ali Azad; Cameron Rink; Surya Gnyawali; Shani Shilo; Gerard J Nuovo; Chandan K Sen
Journal:  Cardiovasc Res       Date:  2009-01-15       Impact factor: 10.787

6.  The microRNA miR-199a-5p down-regulation switches on wound angiogenesis by derepressing the v-ets erythroblastosis virus E26 oncogene homolog 1-matrix metalloproteinase-1 pathway.

Authors:  Yuk Cheung Chan; Sashwati Roy; Yue Huang; Savita Khanna; Chandan K Sen
Journal:  J Biol Chem       Date:  2012-10-11       Impact factor: 5.157

Review 7.  Myocardial repair/remodelling following infarction: roles of local factors.

Authors:  Yao Sun
Journal:  Cardiovasc Res       Date:  2008-12-02       Impact factor: 10.787

8.  Advanced methods for quantification of infarct size in mice using three-dimensional high-field late gadolinium enhancement MRI.

Authors:  Steffen Bohl; Craig A Lygate; Hannah Barnes; Debra Medway; Lee-Anne Stork; Jeanette Schulz-Menger; Stefan Neubauer; Jurgen E Schneider
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-02-13       Impact factor: 4.733

9.  Glutathione disulfide induces neural cell death via a 12-lipoxygenase pathway.

Authors:  H-A Park; S Khanna; C Rink; S Gnyawali; S Roy; C K Sen
Journal:  Cell Death Differ       Date:  2009-04-17       Impact factor: 15.828

10.  Myocardial infarct size and area at risk assessment in mice.

Authors:  Bjorn Redfors; Yangzhen Shao; Elmir Omerovic
Journal:  Exp Clin Cardiol       Date:  2012
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.